Solid Tumor, Unspecified, Adult

UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

Gustave Roussy Cancer Profiling

Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values

Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors

Psychotherapy Intervention for Latinos With Adv Cancer

Psychotherapy Intervention for Latinos With Advanced Cancer

The Safety and Dosimetry Study of 177Lu-LNC1004 Injection

Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors

A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies

68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography for Molecular Assessment of Fibroblast Activation and Risk Assessment in Solid Tumors

Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment

RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors

Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein

Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair